Healthy adults
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (PICOS) Participant: We will include healthy adults without illness (excluding pregnant women (including those planning to become pregnant) and lactating women) and include grade I hypertensive adults (in addition to adults with normal and high-normal blood pressure). Intervention: Oral intake of test food containing GABA (regardless of the form and amount of intake) Comparison: Oral intake of test food without GABA, or no intervention Outcome measurement: Systolic blood pressure, diastolic blood pressure Study design: Randomized controlled parallel trials (RCT-P), randomized controlled crossover trials (RCT-C), quasi-randomized controlled parallel trials (qRCT-P), quasi randomized controlled crossover trials (qRCT-C), non-randomized controlled parallel trials (nonRCT-P), non-randomized controlled crossover trials (nonRCT-C), and non-randomized controlled trials (PECOS) Participant: We will include healthy adults without illness (excluding pregnant women [[including those planning to become pregnant) and lactating women ]and include grade I hypertensive adults (in addition to adults with normal and high-normal blood pressure). Exposure Oral intake of test food containing GABA (regardless of the form and amount of intake) Comparison: Oral intake of test food without GABA. If subgroup analysis of GABA intake amount has been conducted in a study, we define the least intake group as a non-exposure group. Outcome measurement: Systolic blood pressure and diastolic blood pressure Study design: Cohort studies and case-control studies. (Language) Eligibility is not restricted by language.
Exclusion criteria
Exclusion criteria: Exclude proceedings and unpublished studies which don't give us enough research details, and other gray documents that are difficult to verify.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Systolic blood pressure, diastolic blood pressure | — |
Countries
Japan
Contacts
KAGOME CO., LTD. Innovation Division